Bioluminescence imaging allows spatial and temporal progression of viral infection to be detected and quantified in living mice, thereby providing a new approach for studies of viral-host pathogenesis. It has been necessary to construct and validate recombinant reporter viruses that express firefly luciferase to investigate viral replication and spread with this imaging technology. This strategy greatly limits the ability to analyze multiple strains of virus and/or existing viral mutants, and reporter viruses also may be attenuated relative to the respective parental viruses. To facilitate bioluminescence imaging of herpes simplex virus type 1 (HSV-1), we developed a transgenic reporter mouse that uses the promoter from HSV-1 thymidine kinase to control expression of firefly luciferase. Infection with HSV-1 activated expression of firefly luciferase in corneal and flank models of infection, and amounts of bioluminescence increased in proportion to increasing input titers of virus. Imaging could detect infection with three different strains of HSV-1 with the following relative rank order of bioluminescence produced at the site of infection: McKrae N 17 N KOS. Corneal infection with as few as 1 × 10 3 pfu strain McKrae was detectable above background levels. By comparison, infection with vaccinia virus did not affect bioluminescence in the reporter mouse. Collectively, these data establish a new transgenic reporter mouse for infection with HSV-1, thereby enabling in vivo bioluminescence imaging studies of HSV-1 pathogenesis without constructing new reporter viruses.
Herpes simplex virus type 1 (HSV-1) is a neurotropic human pathogen that infects more than 80% of adults. Typically, HSV-1 produces lytic infection in the cornea or other localized epithelial site followed by entry into peripheral nerves and retrograde transport to sensory nerve ganglia. Further viral replication may occur within ganglia, but ultimately viral gene expression is repressed and latency is established.
HSV-1 infection also can spread systemically, particularly in neonates and patients with AIDS, cancer, organ transplantation, or other immunocompromising diseases (Irie et al., 1998; Kimberlin et al., 2001; Pillay et al., 1993) . Diagnosis of disseminated herpes infection frequently is delayed in patients (Kimberlin et al., 2001) , particularly those without skin lesions (Arvin et al., 1982) . Because optimal therapy with antiviral drugs must be initiated before widespread dissemination of virus (Whitley et al., 1991) , systemic HSV-1 infection produces significant morbidity and mortality (Kimura et al., 2002) . Twenty-five percent of neonates with herpes infection develop disseminated infection, and approximately 30% of these patients die from the disease (Kimberlin, 2004) . Therefore, improved understanding of HSV-1 viral-host pathogenesis and immune responses to HSV-1 is needed to identify patients at risk for disseminated infection and develop new therapies for persons with systemic disease.
We previously used bioluminescence imaging (BLI) to investigate infection with a recombinant strain KOS virus that expresses firefly luciferase (FL) under control of the promoter for ICP8 (KOS/dlux) (Summers et al., 2001; Luker et al., 2002) . BLI enables the spatial and temporal progression of infection to be monitored in living mice. Because relative amounts of bioluminescence correlate directly with titers of virus, this system can be used to interrogate effects of host immunity on pathogenesis or quantify effects of antiviral therapy. For example, BLI studies have allowed us to establish functions of type I and II interferons in preventing systemic dissemination of HSV-1 (Luker et al., 2003) .
Previous studies of viral-host pathogenesis with BLI performed by our laboratory and others have used recombinant viruses that express FL (Cook and Griffin, 2003; Luker et al., 2005) . This strategy necessitates that a new reporter virus must be constructed to assay pathogenesis of a different strain of virus or a virus with targeted deletion of a specific gene. As an alternative approach to facilitate BLI studies of HSV-1, we developed a transgenic mouse carrying a reporter that produces bioluminescence in response to HSV-1 infection. The transgene is comprised of the −121 to +52 bases of the promoter from HSV-1 thymidine kinase (TK) linked to firefly luciferase. In response to infection with three different strains of HSV-1, activity of FL in transgenic mice reproduced the established spatial and temporal progression of HSV-1 infection. Amounts of bioluminescence increased with increasing input titers of virus, showing that the TK-FL reporter mouse can be used to quantify relative differences in virus in vivo. Collectively, these data establish the TK-FL reporter mouse for BLI studies of HSV-1 in living mice, allowing studies of viral-host pathogenesis to be accomplished without constructing reporter viruses.
Results

In vitro analysis of HSV-1 luciferase reporters
An optimal HSV-1 promoter-FL reporter construct for detecting infection in vivo with BLI would have low levels of expression under basal conditions and high induction of FL in response to infection with HSV-1. As candidate reporter constructs for imaging, we generated plasmids that used promoters from ICP6, ICP8, or thymidine kinase from HSV-1 to regulate expression of FL. The ICP6 promoter has been used previously to develop a sensitive reporter cell line for detecting HSV-1 infection in vitro (Olivo, 1994) , while ICP8 is the promoter that controls expression of FL in our reporter virus, KOS/dlux (Summers et al., 2001) . While the TK promoter may be used to drive low levels of expression of target genes in cultured cells (Hua et al., 1996) , this promoter also induces high levels of reporter gene activity in response to infection with HSV-1 (Mosca et al., 1985; Smiley et al., 1987) .
To compare these 3 different promoters for expression of FL under basal conditions and after infection with HSV-1, we transiently transfected 293T or Vero cells with each reporter plasmid. Twenty-four hours after transfection, cells were infected with strain KOS at an MOI of 5 or mock-infected. Bioluminescence from FL in the absence or presence of infection was quantified 24 h after infection. Cells also were infected with KOS or KOS/dlux as negative and positive controls for background bioluminescence and robust induction of FL, respectively. The TK-FL reporter had the lowest basal expression of FL and highest induction of bioluminescence after infection among the three reporter constructs (Fig. 1) . For the TK-FL reporter, luciferase activity increased by approximately 50 to 160-fold in cells infected with strain KOS relative to uninfected cells. By comparison, bioluminescence from KOS/ dlux was approximately 10 4 greater than cells infected with strain KOS. The greater net increase in FL with KOS/dlux primarily is due to the lower bioluminescence in uninfected cells relative to the reporter plasmids. Similar data were obtained with infections at an MOI of 1 (data not shown). Based on these data, we selected the TK-FL reporter for developing a transgenic reporter mouse for imaging infection with HSV-1.
We also used the ICP6-FL reporter construct to prepare a transgenic mouse. This selection was based upon the published success for detecting infection with HSV-1 in cells that have this reporter stably integrated into the genome. Because regulatory elements for genes are known to function differently in transiently versus stably transfected cells (Berland and Chasin, 1988), we hypothesized that induction of the ICP6-FL reporter might be improved as a transgene integrated into the genome.
In vivo screening of founder mice
Our initial strategy was to establish transgenic reporter mice in inbred and outbred strains of mice. This approach would allow us to exploit genetically engineered inbred mice for studies of HSV-1 pathogenesis and also have a model that reproduces the genetic heterogeneity of human populations infected with the virus. We obtained 4 founder mice in a hybrid strain of C57BL/6 and C3H that had germline transmission of the TK-FL transgene, and 3 founder CD-1 mice carried the ICP6-FL reporter. Mice with either transgene appeared normal phenotypically, suggesting that the transgenes had no deleterious effects on the mice.
We used BLI imaging to monitor expression of FL under basal conditions and in response to corneal infection with strain 17 HSV-1. Mice were infected with 1 × 10 6 pfu strain 17 by corneal scarification in the right eye, while the left eye of each mouse was mock-infected as a control for nonspecific induction of FL. Qualitative and quantitative expression and distribution of bioluminescence in each eye were assayed with BLI performed 1 day prior to infection and daily for 8 days post-infection. Representative images from each line of TK-FL transgenic mice on day 5 after infection are shown in Fig. 2A .
Each of the four lines of TK-FL transgenic mice showed increased bioluminescence in the infected right eye and periocular tissues. This distribution reproduced the expected progression of ocular infection with HSV-1 in mice as determined with KOS/dlux, although we cannot validate that every cell infected with HSV-1 also produces bioluminescence. By region-of-interest (ROI) analysis, the relative increase in FL activity produced by infection ranged from approximately 3-fold in line 2 to 30-fold in line 4. Mock-infected left eyes showed no detectable increase in bioluminescence in any of the four lines of TK-FL transgenic mice ( Fig. 2A) . As a control for specificity, we infected TK-FL transgenic mice with vaccinia virus, an unrelated DNA virus that also encodes a thymidine kinase gene. Unlike infection with HSV-1, corneal infection with vaccinia virus did not affect bioluminescence in TK-FL transgenic mice (Fig. 2B ). These data show that transgenic mice with the TK-FL transgene were not general reporters of viral infection. BLI imaging also showed a variable amount of bioluminescence in the absence of infection in TK-FL mice. This background bioluminescence was observed predominantly in the paws and tail, although FL activity also could be detected in the ears (see Fig. 3 ).
ICP6-FL mice also had background bioluminescence in paws, tail, and ears that was similar to that observed in TK-FL mice (data not shown). However, ICP6-FL mice showed no detectable change in luciferase activity following corneal infection with 1 × 10 6 pfu strain 17 or strain KOS (data not shown). Based on these data for TK-FL and ICP6-FL mice, we used transgenic line 4 of TK-FL mice for further BLI studies of HSV-1 infection. Line 4 of TK-FL mice was selected based on its relatively low background level of bioluminescence and high induction of FL activity at the site of infection. These mice are designated as TK-FL reporter mice.
Ocular infection with HSV-1 strains
One of the primary objectives in developing the TK-FL reporter mouse was to enable imaging studies of different strains of HSV-1 without producing new recombinant viruses. To determine the extent to which the TK-FL mouse functions as a general reporter for HSV-1 infection, we infected mice with 1 × 10 6 pfu of KOS, 17, or McKrae in the right eye. As a control for non-specific induction of FL, mice were mock-infected in the left eye. Progression of infection was detected and quantified with daily BLI studies. FL activity first was induced in the mouth of TK-FL mice (Figs. 3A-C). This activity likely was due to virus draining from the infected eye to the nasopharynx and oropharynx via the nasolacrimal duct, although it potentially could be due to the host response to infection. For strains 17 and McKrae, bioluminescence in the mouth was detected on days 1-2 postinfection, while this could not be detected confidently until day 3 for mice infected with KOS. It is important to note that careful positioning of the front paws was necessary to prevent bioluminescence from reflecting off the mouth of mice (compare days 0 and 1 in Fig. 3A ). Minimal bioluminescence in the infected right eye could be seen with BLI on day 2 post-infection, but FL activity in the eye and periocular tissues more typically was observed on day 3 for all strains of virus. As expected from our previous studies with KOS/dlux, bioluminescence peaked on days 5-6 post-infection, at which time most of the FL activity was present in periocular tissues. No bioluminescence could be detected in the uninfected left eye of these adult mice (Fig. 3C) . FL activity at the site of infection decreased to approximately baseline levels on day 7 post-infection for strains KOS and 17, while bioluminescence was detectable through day 8 in TK-FL mice infected with strain McKrae. Overall, the general spatial and temporal changes in bioluminescence reproduced the established progression of HSV-1 infection in mice, demonstrating that the TK-FL reporter mice can be used for BLI studies of pathogenesis.
We used ROI analysis to quantify relative increases in amounts of bioluminescence produced in response to infection with various strains of HSV-1 (Fig. 3D) . Increases in bioluminescence were greatest for infection with strain McKrae. Peak levels of FL activity increased by approximately 125-fold for strain McKrae, while amounts of bioluminescence were approximately 26-and 9-fold above background for strains 17 and KOS, respectively. The total increase in bioluminescence produced by infection with the various strains of HSV-1 was quantified by area-under-thecurve (AUC) analysis of photon flux data (Fig. 3E) . Total photon flux at the site of infection, including the eye and periocular tissues, was significantly greater for TK-FL mice infected with McKrae, as evidenced by AUC values that were approximately 5-and 10-fold greater than determined for strains 17 (P b 0.005) and KOS (P b 0.001), respectively. AUC over the period of acute infection with strain 17 also was significantly greater than KOS (P b 0.05). These data suggest that amounts of bioluminescence correspond to relative virulence of these three viruses, although we cannot exclude the possibility that activity of the reporter is affected by differences in host response to infection.
Infections described above were performed in adult mice ranging in age from 7 to 10 weeks old. To investigate the extent to which infection with HSV-1 is affected by age of mice, we infected 3-week-old mice with strain McKrae. At 3 weeks of age, immune systems of mice are reported to be mature (Martinez et al., 1999) . Mice were infected in the right eye with 1 × 10 6 pfu of strain McKrae, while the left eye was intentionally not infected or mock-infected. Increases in bioluminescence in the infected right eye and periocular tissues occurred as expected from studies with adult animals (Fig. 4) . Unlike adult mice, we also noted that luciferase activity in 3 of 5 mice increased in periocular tissues on the left with intensities that were similar to those on the infected right side. While we cannot exclude the possibility that luciferase activity on the left side is activated solely by the host response, these results suggest that spread of infection to the contralateral side may occur in this younger population of mice. Collectively, these data with ocular infection indicate that BLI of the TK-FL reporter mouse can detect and quantify infection with multiple wildtype strains of HSV-1.
Bioluminescence response to various input titers of virus
Having determined that infection of TK-FL mice with different strains of HSV-1 could be detected with in vivo imaging, we next investigated to what extent imaging data could differentiate among different input titers of virus used for infection. We infected mice via corneal scarification with input titers of strain McKrae between 1 × 10 3 and 1 × 10 6 pfu in the right eye. The left eye of each mouse was mock-infected as a control. BLI was performed daily for 8 days to monitor acute infection, and data for increases in bioluminescence in the infected right eye and periocular tissues of each mouse relative to the same area in the mock-infected left eye were quantified by ROI analysis.
BLI data showed that infection with increasing input titers of strain McKrae produced proportionate increases in bioluminescence over the course of acute infection (Fig.  5A) . Using strain McKrae, input titers of 1 × 10 3 pfu were detectable over background levels in the TK-FL reporter mice. AUC analysis of total photon flux showed statistically significant differences in bioluminescence among various input titers of virus, demonstrating that the reporter mouse can be used to distinguish graded amounts of HSV-1 in vivo (Fig. 5B) (P b 0.01) .
To extend these observations to another strain of HSV-1, we also infected TK-FL mice with different input titers of strain 17 via corneal scarification (Fig. 5C ). Similar to results with McKrae, BLI data for photon flux at the site of ocular infection increased as more strain 17 were used for infection. Bioluminescence produced by infection with 1 × 10 4 and 1 × 10 5 pfu of strain 17, respectively, was lower than that produced 1 × 10 6 pfu (see Figs. 3B and D) , although the latter amount of virus was not compared directly in this experiment. For strain 17, an input titer of 1 × 10 4 pfu was detectable with BLI, but an inoculum of 1 × 10 3 pfu could not be measured reliably above background. AUC analysis confirmed a statistically significant difference in photon flux measured in TK-FL mice infected with 1 × 10 4 and 1 × 10 5 pfu, respectively ( Fig. 4D ) (P b 0.05). The sensitivity of the reporter mouse for infection is less than that reported with our recombinant strain KOS virus that expresses firefly luciferase (KOS/dlux) (Luker et al., 2002) . Nevertheless, these data confirm the direct relationship between input titers of two different strains of HSV-1 and bioluminescence produced during the period of acute infection in TK-FL mice.
Cutaneous infection with HSV-1 in the flank
We used a cutaneous route of infection to determine the extent to which the TK-FL reporter mice could be used to monitor a second route of infection. Fur overlying both flanks of mice was removed with clippers and Nair, and the skin was abraded gently with a Dremel tool to facilitate infection (Stock et al., 2004) . Animals were infected with 1 × 10 6 pfu strain 17 in the right flank, while the left flank was mock-infected as a control. Daily BLI studies showed that a low level of bioluminescence could be detected at the site of flank infection on day 2 (Fig. 6A) . The amount and distribution of FL activity increased progressively through day 4 and subsequently returned to baseline by day 6. By comparison, only minimal bioluminescence was observed in the mock-infected left flank on day 4 (Fig. 6A and data not shown) . ROI analysis of photon flux verified the increase and subsequent decrease in FL activity during acute infection, showing that the reporter mouse can detect HSV-1 infection in at least two different models of infection.
Discussion
Studies by our laboratory and others have demonstrated that in vivo BLI is an important new technology for studying pathogenesis of viral and bacterial pathogens (reviewed in Doyle et al., 2004) . Previous imaging studies of host-pathogen interactions have been accomplished with recombinant viruses or bacteria that have been engineered to express luciferase enzymes as reporters. This strategy has several limitations, such as possible attenuation of the pathogen by insertion of the reporter gene and the time required to construct recombinant viruses or bacteria. These potential problems decrease the ability of investigators to study various strains of the same pathogen or effects of mutations in genes of interest.
We have developed a transgenic reporter mouse that uses the promoter from HSV-1 thymidine kinase to control expression of FL, thereby overcoming these limitations for using BLI to monitor HSV-1 infection. Bioluminescence at the site of infection increased in response to HSV-1 infection, but no change in activity of FL was detected following infection with vaccinia virus, an unrelated DNA virus. Infections with strains KOS, 17, and McKrae all were detected with BLI, and relative amounts of bioluminescence increased in accordance with the rank order of virulence of these three strains. Changes in bioluminescence at the site of infection were proportional to input titers of virus, showing that the TK-FL mouse can distinguish among different amounts of virus in vivo. These data support our conclusion that luciferase activity corresponds directly with viral replication, although it is possible that differences in host response to infection contribute to overall changes in bioluminescence. Collectively, these data show that the TK-FL mouse is a general tool for assaying HSV-1 infection in mouse models.
Our data show that TK-FL mice can be used to monitor infection with HSV-1 in the corneal and flank models of infection. Both of these routes of infection have been used to investigate key aspects of viral-host pathogenesis during acute infection and reactivation from latency Leib et al., 2000; Liu et al., 2000) . Because the TK-FL mouse allows infections with strains 17 and McKrae to be investigated in vivo, this reporter mouse offers the potential for in vivo studies of viral and host factors that affect reactivation from latency. The ability to study this important aspect of HSV-1 pathogenesis in living mice may provide new insights into mechanisms that regulate this process and allow in vivo testing of new methods to prevent or limit reactivation.
In 3-week-old TK-FL mice, we determined that bioluminescence commonly could be detected in the uninfected eye in addition to the infected eye after corneal scarification. Previous studies have demonstrated interocular spread of HSV-1 from an infected to uninfected eye after injection of virus into the anterior chamber (Whittman et al., 1984; Atherton and Streilein, 1987; Geiger et al., 1994) . In the anterior chamber model of infection, HSV-1 spreads to the uninfected eye within 1 day of infection, while a second wave of virus in the eye occurs 7-10 days after infection. The delayed wave of HSV-1 in the uninfected eye is due to trafficking via the optic nerve, but the route for initial interocular spread of HSV-1 is characterized poorly. To our knowledge, a similar process has not been reported for spread of HSV-1 to the uninfected eye in young mice. Although the mechanism for this process in 3-week-old mice currently is unknown, the appearance of luciferase activity in the uninfected eye by 4 days after infection does not appear to be consistent with the kinetics of spread via the optic nerves.
Although the TK promoter generally is regarded to be active constitutively (Hua et al., 1996) , the TK-FL reporter showed robust induction of bioluminescence in response to infection with HSV-1. The strong expression of luciferase after infection emphasizes that TK and all other early genes in HSV-1 are regulated by immediate early genes. By comparison, the ICP6 promoter, which typically is considered as an inducible promoter, did not respond to infection in 3 different lines of transgenic mice. Several different factors may account for the differences between these 2 different transgenic reporter mice. It has been established that HSV-1 can have differing effects on regulation of genes integrated into the viral versus cellular genomes (Smibert and Smiley, 1990) . Expression of transgenes also is affected by position in the cellular genome. We did not investigate integration sites of the ICP6-FL transgene in mouse chromosomes, so it is possible that the reporter was repressed in all 3 lines of mice bearing this reporter construct. Finally, we cannot completely exclude that differences in strains of mice affected activation of the TK-FL and ICP6-FL reporters, respectively, although other transgenic mice have been established successfully in the CD-1 strain (Tsoporis et al., 1998) .
The existing TK-FL mouse was analyzed in a mixed genetic background of C57BL/6-C3H. While this hybrid strain enabled successful establishment of transgenic founder mice, there are a limited number of genetically altered mice in this same background. Mating the existing TK-FL mice to other mice with specific mutations or deletions in key immunoregulatory genes is expected to further enhance the uses of the reporter mouse for studies of HSV-1 pathogenesis.
Our data demonstrate that the TK-FL reporter mouse can be used to detect infection with various strains of HSV-1, but there are limitations to this transgenic mouse relative to reporter viruses engineered to express FL. The lower limits of detection for ocular infection with the TK-FL mouse are an input titer of 1 × 10 3 pfu, which is approximately 10-fold higher than the minimum titer of KOS/dlux that can be detected with BLI (Luker et al., 2002) . The decreased sensitivity of the reporter mouse also is evident in the time interval between infection and initial detection of bioluminescence with imaging. HSV-1 infection first can be detected on days 2-3 post-infection in the TK-FL mouse, while low levels of bioluminescence are observed in the eye on day 1 after infection with KOS/dlux (Luker et al., 2002) . These data imply that numbers of copies of reporter DNA, transcription, and/or translation of FL are greater when the reporter is integrated into the viral genome as compared with the host. We also noted that bioluminescence was detected in the mouth of infected mice, a finding that was not observed in previous studies with the recombinant strain KOS virus that expresses firefly luciferase (Luker et al., 2002 (Luker et al., , 2003 . Potentially, this may be due to the use of a slightly larger volume of medium for infecting eyes in the current study, although we cannot exclude the possibility that reporter activity in the mouth is regulated by a cellular response to infection. It also is possible that differences in distribution of bioluminescence may be attributed to variations between strains of mice.
The transgenic reporter mouse also has relatively high levels of FL activity in paws, ears, and the tail under basal conditions. These sites of background bioluminescence have been observed in other transgenic mice that use FL as a reporter gene (Ryan and Scrable, 2004) . FL activity in the skin is detected more readily with BLI because there is minimal attenuation by intrinsic pigmentation of organs or overlying fur. Potentially, bioluminescence may be greater in these sites because of slightly lower body temperature in the extremities of mice. FL is heat labile with a biologic half-life of approximately 3 min at 37°C (Baggett et al., 2004) , so small decreases in temperature in superficial tissues could stabilize the protein and increase bioluminescence. While background bioluminescence did not limit BLI studies of infection in the eye or flank, these mice will have limited usefulness for imaging the footpad route of infection.
In summary, we have established a transgenic reporter mouse that expresses FL in response to HSV-1 infection. The TK-FL mouse shows titer-dependent production of bioluminescence and responds to three commonly used laboratory strains of HSV-1. This reporter mouse allows BLI studies of HSV-1 without the need to make a reporter virus, thereby enabling in vivo imaging studies of existing strains and mutants of HSV-1. We anticipate that the TK-FL mouse will complement our existing reporter virus (KOS/dlux) as important tools for investigating HSV-1 pathogenesis and testing new antiviral therapies.
Materials and methods
Plasmids
A fragment containing bases −121 to +52 of the promoter for HSV-1 thymidine kinase was excised from TK-luciferase (gift of Stuart Adler, Washington University) with EcoRI and NotI and ligated to the SmaI site of pGL3 basic (Promega) to generate TK-pGL3. The promoter for HSV-1 ICP6 was removed from pGL2 basic (Promega) (gift of Paul Olivo) with SmaI and HindIII and ligated to the corresponding sites in pGL3 basic to produce ICP6-pGL3. The promoter and FL were removed from TK-pGL3 and ICP6-pGL3, respectively, with NotI and XbaI. This fragment of DNA (TK-FL) was isolated and purified with a Qiaex II kit (Qiagen) to inject for production of transgenic mice. A FL reporter plasmid containing the promoter for ICP8 has been described previously (Summers et al., 2001) .
Cells
293T and Vero cells were cultured in DMEM medium with 10% heat-inactivated fetal bovine serum, 1% L-glutamine, and 0.1% penicillin-streptomycin in a 5% CO 2 incubator at 37°C.
Viruses
HSV-1 strains KOS, 17, and McKrae were propagated and titrated on Vero cells as described (Rader et al., 1993) . The recombinant strain KOS virus expressing FL from the ICP8 promoter (KOS/dlux) has been characterized previously (Summers et al., 2001) . Western Reserve (WR) vaccinia virus (gift of Andrew Pekosz, Washington University) was propagated, purified, and titered according to published protocols (Earl et al., 1998) .
In vitro assays of luciferase reporters
293T or Vero cells were plated at 35,000 cells per well in 24-well plates 1 day prior to transfection with 1 μg of various HSV-1 promoter reporter constructs. Transfections were performed with Fugene 6 (Roche). Twenty-four hours after transfection, cells were infected with HSV-1 strain KOS at an MOI of 1 or 5. Cells were lysed 24 h after infection, and amounts of firefly luciferase activity were quantified with a luciferase assay kit (Promega) and a luminometer (Turner). Data for luciferase activity were expressed as relative light units per mg protein as measured by BCA assay (Pierce).
Transgenic mice
Transgenic mice carrying either the TK-FL or ICP6-FL reporter were prepared by the core facility in the Department of Ophthalmology and Visual Sciences at Washington University School of Medicine. TK-FL mice were a hybrid strain of C57BL/6-C3H mouse, while ICP6-FL transgenic mice were in a CD-1 strain. Founder mice bearing the transgene were identified by PCR analysis of tail samples, using the primers forward 5′ AGACGCCAAAAACATAAAGAAAGG-CCCGGC 3′ and reverse 5′ AGACGCCAAAAACATAAAG-AAAGGCCCGGC 3′. Four different TK-FL transgenic mice and 3 lines of ICP6-FL mice were obtained, respectively. Transgenic mice from each founder line were characterized for induction of luciferase activity in response to infection with HSV-1. The line of transgenic mice with highest induction of luciferase following infection was used for subsequent experiments. For these mice, transgenic pups were identified by bioluminescence imaging for the presence of bioluminescence in paws of uninfected mice after intraperitoneal injection of Dluciferin.
Infection of mice
Mice were infected with HSV-1 strains KOS, 17, or McKrae at titers between 1 × 10 3 and 1 × 10 6 pfu as indicated in figure legends. Animals were between 7 and 10 weeks old at the time of experiments, except for the specific experiment that analyzed ocular infection with strain McKrae in 3-week-old mice. Ocular infections were performed by corneal scarification followed by administration of virus in 2.5 μL of DMEM medium (Invitrogen) (Rader et al., 1993) . For flank infection with HSV-1, hair was removed from mice with electric clippers and Nair. The skin was abraded with a Dremel tool and infected with 1 × 10 3 to 1 × 10 6 pfu in 20 μL DMEM according to a published protocol (Stock et al., 2004) . A sterile bandage was kept over the site of infection for the first 24 h.
Bioluminescence imaging
Bioluminescence imaging was performed with a cryogenically cooled CCD camera (IVIS, Xenogen). Acquisition and analysis of images were performed as described previously (Luker et al., 2002) .
Data analysis
Data for in vitro and in vivo experiments are reported as mean values ± SEM. Data were analyzed by t test to determine statistically significant differences (P b 0.05) using Graphpad software (Prism).
